Professional Products and Services LLC has earned the Joint Commission's Gold Seal of Approval as a Medical Supply Company located in Central Florida, USA.
- The Ecrinal Range of treatments for hair loss is based on A.N.P.®
- RESULT: STRONGER HAIR AND NAILS, FASTER GROWTH
ANP® (horse mane extract) is an exclusive and internationally patented ingredient used by Laboratoires Asepta in the Ecrinal Range for hair and nail care.
ANP® is an active natural ingredient rich in omega 3 fatty acids. It stimulates the production of keratin.
Different pharmaceutical forms of this active ingredient have been used in the Ecrinal Range to allow the full benefits of its properties to be made use of in the nail care range and the treatment of hair loss, hair maintenance and health including eyelashes and eyebrows.
In the majority of mammals, the hair bulb is located in a layer of a very particular type of oily tissue. The permanent presence of this oily mass suggests that it is necessary for hair growth. These observations were made in animals with manes such as lions, giraffes, horses, etc.
The discovery that this oily substance has a highly beneficial effect on the phaneres (keratinised parts of the human body: nails, eyelashes and hair) was made in a hospital. The spectacular results obtained with nails led scientists to study this new active substance very carefully.
A team of French hospital pharmacists, in collaboration with the ASEPTA Laboratories, have developed a method for separating and purifying Horsemane Tricholipids or A.N.P.® (Natural Hair and Nail Activator) exclusively used by the ASEPTA Laboratories in our ECRINAL ANP® nail, eyelash and hair range.
Histochemical studies have shown that Tricholipids® mobilise an active form of sulphur, the thiol or SH groups. This points to an active growth and regeneration metabolic process, vital to active biosynthesis of cysteine and methionine, the sulphurated amino acids which are vital constituents of nails and hair.
Pharmacological studies have shown that certain specific enzyme activities, such as phosphatase activity in tissue located at the base of hairs, increase after treatment with Tricholipids.
Tricholipids penetrate very quickly which means faster tissue mobilisation and stimulation of bulb activity leading to hair growth.
A.N.P. contains specific substances and a high concentration of essential fatty acids including linoleic acid of the omega 3 family. Its intense biodynamic stimulation of hair and nail growth has been confirmed by pharmacodynamic studies and a clinical study.
Treatment consisted of vials containing 40% ANP®
Study conducted under dermatological supervision by:
The effect of the product ECRINAL A.N.P. 40® VIALS was evaluated in 71 men and 22 women (total: 93 patients). It is important to note that the cause of hair loss in men and women can be very different. This means the benefits of the treatment in the two sexes can be understood better.
Number of applications:
After 2 Months of Treatment, hair loss stopped or was considerably reduced in 85% of Cases
After 4 Months of hair re growth treatment, there was obvious hair re-growth in 67% of cases, while 11% of cases showed the growth of baby hair.
(Study conducted n people with hyperseborrhoea, a common cause of alopecia in men) After 4 Months of Treatment, a distinct improvement in seborrhoea was noted in 91% of cases.
Good results, especially for male seborrhoeic alopecia,
often the most disabling and hardest to treat.
HAIR LOSS STOPS OR 3/4 DECREASE |
HAIR LOSS HALVED |
NO ACTIVITY |
|
|---|---|---|---|
| IN WOMEN | 14 |
5 |
5 |
| IN MEN | 51 |
9 |
9 |
| TOTAL | 65 |
14 |
14 |

VERY OBVIOUS RE-GROWTH OR 3/4 DECREASE |
GROWTH OF 'BABY HAIR' |
NO
ACTIVITY |
|
|---|---|---|---|
| IN WOMEN | 9 |
2 |
3 |
| IN MEN | 34 |
5 |
11 |
| TOTAL | 43 |
7 |
14 |

A reduction in seborrhoeic flow after 2 months, and an improvement after 4 months.
VERY OBVIOUS IMPROVEMENT |
MODERATE IMPROVEMENT |
NO ACTIVITY |
|
|---|---|---|---|
| IN WOMEN | 6 |
4 |
1 |
| IN MEN | 29 |
12 |
4 |
| TOTAL | 35 |
16 |
5 |

VERY GOOD RESULTS |
AVERAGE RESULTS |
NO CHANGE |
|
|---|---|---|---|
| IN WOMEN | 9 |
2 |
0 |
| IN MEN | 36 |
3 |
1 |
| TOTAL | 45 |
5 |
1 |

Ecrinal ANP40® treatment has been shown to be very well tolerated
during periods of 2 months and longer.
VERY GOOD AND GOOD |
AVERAGE IMPOVEMENT |
|
|---|---|---|
| IN MEN AND WOMEN | 92% of cases |
8% of cases |
------------
------------
Parameters Assessed:
A significant anti-hair loss and redensifying effect is observed by the vounteers themselves: